Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation
Photosensitizer†,‡ - Senge - 2011 - Photochemistry and Photobiology - Wiley Online Library …

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Malignant pleural mesothelioma (MPM) is considered to be a relatively rare tumour. In Great
Britain, the incidence in males is 3.4/100 000, in France it is 2.3/100 000 and in the …

Objectives: Our aim was to identify prognostic variables for long-term postoperative survival
in trimodality management of malignant pleural mesothelioma. Methods: From 1980 to 1997 …

Background: Surgical resection of malignant pleural mesothelioma is reported to have up to
an 80% rate of local recurrence. We performed a phase II trial of high-dose hemithoracic …

Purpose: To describe the initial experience at Dana-Farber Cancer Institute/Brigham and
Women's Hospital with intensity-modulated radiation therapy (IMRT) as adjuvant therapy …

Background: The aim of this multicenter trial was to prospectively evaluate neo-adjuvant
chemotherapy followed by extrapleural pneumonectomy (EPP) and radiotherapy, including …

Purpose Malignant pleural mesothelioma (MPM) remains associated with poor outcome. We
examined the results of trimodality therapy with cisplatin-based chemotherapy followed by …

Background. The factors influencing outcome after resection of malignant pleural
mesothelioma (MPM) are controversial. This analysis of a prospective surgical database …

OBJECTIVE: Local recurrence limits long-term survival in patients with malignant pleural
mesothelioma. We investigated whether hyperthermic intraoperative cisplatin chemotherapy …